Skip to main content
. Author manuscript; available in PMC: 2014 Apr 21.
Published in final edited form as: J Investig Med. 2010 Dec;58(8):945–949. doi: 10.231/JIM.0b013e3181fb7ca7

Table 4.

Cross tabulation of year 2005 samples based on C-LDL-C and D-LDL-C at clinically meaningful LDL-C treatment goals. Numbers along the diagonal of the table (in bold) indicate where the measures agree. Numbers in the off-diagonal cells indicate some level of disagreement.

C-LDL-C D-LDL-C Treatment Goal (mg/dl)
Treatment
Goal (mg/dl)
<70 70 – 100 100 – 130 130 – 160 ≥ 160 Total
<70 77 73 1 0 0 151
70 – 100 9 226 90 0 0 325
100 – 130 0 12 182 62 0 256
130 – 160 0 0 15 99 27 141
≥ 160 0 0 2 5 57 64
Total 86 311 290 166 84 937

Kappa Statistic: 0.5803 (0.5406, 0.6201)

Generalized McNemar Test: p < 0.001

HHS Vulnerability Disclosure